Cart
sales@molnova.com
YF-2
CAS No. 1311423-89-8
YF-2( YF 2 )
Catalog No. M20208 CAS No. 1311423-89-8
YF-2 is blood-brain-barrier permeable histone acetyltransferase activator acetylates H3 in the hippocampus CBP PCAF and GCN5 with EC50s of 2.75 μM 29.04 μM and 49.31 μM respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 126 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 575 | In Stock |
|
| 100MG | 817 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYF-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionYF-2 is blood-brain-barrier permeable histone acetyltransferase activator acetylates H3 in the hippocampus CBP PCAF and GCN5 with EC50s of 2.75 μM 29.04 μM and 49.31 μM respectively.
-
DescriptionYF-2 is blood-brain-barrier permeable histone acetyltransferase activator acetylates H3 in the hippocampus CBP PCAF and GCN5 with EC50s of 2.75 μM 29.04 μM and 49.31 μM respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsYF 2
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorCBP|PCAF|GCN5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1311423-89-8
-
Formula Weight430.85
-
Molecular FormulaC20H22ClF3N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (290.12 mM);Water:Insoluble
-
SMILESCCOc1cccc(OCCN(C)C)c1C(=O)Nc1ccc(Cl)c(c1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.FENG Yen et al. HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF. WO 2011072243A1.
molnova catalog
related products
-
KDM1A-IN-29
KDM1A-IN-29 is a histone demethylase inhibitor.
-
LSD1-IN-20
Lsd1-in-20 is a potent dual inhibitor of LSD1/G9a with Ki values of 0.44 and 0.68 μM, respectively.
-
GSK-LSD1 dihydrochlo...
GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
